Skip to main content

Site notifications

TRADENAME TO BE CONFIRMED Seqirus Pty Ltd

Product name
TRADENAME TO BE CONFIRMED
Sponsor
Accepted date
Sep-2025
Active ingredients
Influenza virus haemagglutinin
Proposed indication
Influenza virus haemagglutinin is a vaccine proposed for the active immunisation against influenza in persons 50 years of age and older.
Application type
A (new medicine)
Publication date
Sep-2025